The
following potential common share equivalents were excluded from the calculation of diluted net income per share because their effect
would have been anti-dilutive in the period presented (in thousands):
Schedule
of Antidilutive Securities Earnings Per Share
| | |
June 30, | | |
December 31, | |
| | |
2026 | | |
2025 | |
| Convertible preferred stock | |
| 18,707 | | |
| 20,782 | |
| Common Stock Warrants | |
| 7,656 | | |
| 26,421 | |
| Preferred Stock Warrants | |
| 247 | | |
| 247 | |
| Stock options | |
| 15,352 | | |
| 7,337 | |
| Total potential common stock excluded from net loss per share | |
| 41,962 | | |
| 54,787 | |
|